- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens filmless order from Canadian hospital
Siemens filmless order from Canadian hospitalSiemens Medical Systems has landed a $3 million (Canadian) order to install its Sienet PACS at Charles LeMoyne Hospital in Quebec. The 600-bed hospital will become the first filmless hospital in
Siemens filmless order from Canadian hospital
Siemens Medical Systems has landed a $3 million (Canadian) order to install its Sienet PACS at Charles LeMoyne Hospital in Quebec. The 600-bed hospital will become the first filmless hospital in Quebec, according to Siemens Canada, headquartered in Mississauga, Ontario. The Sienet PACS will employ an Ethernet and Fast Ethernet-powered network to link electronic retrieval and remote viewing stations. Six workstations will be available for image diagnosis, with 21 consoles slated to be installed throughout the hospital for consultation. The system is expected to be ready for use this summer, according to the company.
- Search again
- Homepage
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
